Cite
HARVARD Citation
Segman, Y. et al. (2021). Outcome of relapsed/refractory diffuse large B-cell lymphoma patients treated with polatuzumab vedotin-based therapy: real-life experience. Leukemia & lymphoma. 62 (1), pp. 118-124. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Segman, Y. et al. (2021). Outcome of relapsed/refractory diffuse large B-cell lymphoma patients treated with polatuzumab vedotin-based therapy: real-life experience. Leukemia & lymphoma. 62 (1), pp. 118-124. [Online].